Abu Dhabi Launches Drug and Poison Information Service to Improve Healthcare Outcomes
Abu Dhabi has launched its Drug and Poison Information Service. The aim is to raise awareness on the safe drugs use and the necessary procedures to prevent poisoning. This will strengthen research efforts in the Emirate to further develop the clinical toxicology field and improve healthcare outcomes. In 2023 the goal is to increase the working hours of the hotline service to become around the clock.
Recent Posts
Joint Scientific Consultation EU Strategies for Medical Device Companies
The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...
Insights on EU Joint Clinical Assessment for High-Risk Medical Devices
EU Joint Clinical Assessment is a distinct, harmonised process that operates separately from CE marking. It produces comparative clinical evidence on selected high-risk devices to support more consistent national reimbursement decisions across EU member states. Insights from the
USTR Germany Pharma Investigation and its Impact on Global Drug Pricing
The USTR Germany Pharma Investigation has exposed how Germany’s pharmaceutical reimbursement policies force American patients to finance a disproportionately large share of worldwide drug research and development. By systematically suppressing prices below sustainable levels, these practices erod...